Improving the diagnosis, management and control of chlamydial infections in Australian livestock. Chlamydial diseases, such as arthritis and encephalomyelitis, are associated with significant economic losses for Australian livestock producers. Effective surveillance and management of Chlamydia infections is problematic due to: the absence of epidemiological data; the lack of an accurate and easily interpretable diagnostic test; and the lack of an available vaccine. This project aims to evaluate ....Improving the diagnosis, management and control of chlamydial infections in Australian livestock. Chlamydial diseases, such as arthritis and encephalomyelitis, are associated with significant economic losses for Australian livestock producers. Effective surveillance and management of Chlamydia infections is problematic due to: the absence of epidemiological data; the lack of an accurate and easily interpretable diagnostic test; and the lack of an available vaccine. This project aims to evaluate factors associated with chlamydial disease in Australian livestock and thereby improve on-farm diagnosis. With the concomitant development of a chlamydial vaccine for sheep, this project aims to provide veterinarians and producers with important tools to reduce the on-farm impacts of chlamydial disease.Read moreRead less
A next-generation whole parasite bovine Babesia vaccine. . In Australia, Babesia parasites cause most of the severe and often fatal cases of cattle-tick fever, a globally significant tick-borne disease. It can be prevented by a live-attenuated parasite vaccine which has critical limitations of a 4-day shelf-life and risk of severe disease if administered to adult cattle. This project aims to evaluate in cattle a novel whole parasite Babesia bovis vaccine that cannot cause disease and can be pres ....A next-generation whole parasite bovine Babesia vaccine. . In Australia, Babesia parasites cause most of the severe and often fatal cases of cattle-tick fever, a globally significant tick-borne disease. It can be prevented by a live-attenuated parasite vaccine which has critical limitations of a 4-day shelf-life and risk of severe disease if administered to adult cattle. This project aims to evaluate in cattle a novel whole parasite Babesia bovis vaccine that cannot cause disease and can be preserved as an off-the-shelf product without losing efficacy. The expected outcome is a significantly improved vaccine for a major infectious disease that affects primary food production. As the disease imposes a major economic burden, it will have great benefit for the Australian livestock industry.
Read moreRead less